Opportunity overview
NHS Blood and Transplant (NHSBT) are seeking a provider for Next Generation Sequencing (NGS) QC testing requirements for the Cellular and Molecular Therapies (CMT) directorate, namely the Clinical Biotechnology Centre (CBC). CBC handle a number of products in the production of Advanced Therapeutic Investigational Medicinal Products (ATMPs) and starter material master cell banks (MCBs). These require NGS QC testing services that meet specific regulatory requirements.
Awarded to
Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.
SGS United Kingdom Limited
- Published award value
- £407.2k
- Awarded
- 23 Jun 2026
- Award ID
- 1
- Status
- pending
- Identifier
- GB-PPON PLYM-7548-BZWR
- Location
- Ellesmere Port, UKD63, CH65 3EN, United Kingdom
Classification
No classification was supplied.
Lots
- Lot 1Value not stated
Documents and notices
- Contract award notice on Find a TenderOpen source ↗